Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
346 GBX | -1.14% | +12.34% | +22.26% |
11:55am | Hutchmed Starts Phase 2/3 Trial of Surufatinib Combination Therapy in Pancreatic Cancer | MT |
05:11am | Hutchmed Starts Phase 2/3 Trials for Pancreatic Cancer Drug in China; Shares Rise 3% | MT |